Procrit — Medica
Anemia associated with myelodysplastic syndrome
Initial criteria
- Patient is age ≥ 18 years
- Patient has a hemoglobin < 10.0 g/dL OR a serum erythropoietin level ≤ 500 mU/mL
- Patient is currently receiving iron therapy OR has adequate iron stores according to the prescriber
- Medication is prescribed by or in consultation with a hematologist or oncologist
Reauthorization criteria
- Patient is age ≥ 18 years
- Patient has a hemoglobin ≤ 12.0 g/dL
- Patient is currently receiving iron therapy OR has adequate iron stores according to the prescriber
- Medication is prescribed by or in consultation with a hematologist or oncologist
Approval duration
1 year